ArticleThe Indian journal of medical research2025
A qualitative study on the barriers to tuberculosis treatment adherence using digital adherence technologies (DATs).
Article in The Indian journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- "Fragmented care pathway in a layered TB care system": a grounded theory approach to understand care pathways and delays in TB care in Odisha.BMC health services research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background & objectives In order to meet the ambitious aim set by the Government of India as well as the sustainable development goals (SDG) target for eliminating tuberculosis in 2030, it is important for the healthcare providers to follow and support the patients throughout the treatment for its successful completion. For monitoring the tuberculosis treatment compliance, Digital Adherence Technologies (DATs) play a major role. DATs are digital tools that use mobile phone, computer, or sensor technologies to support the capture of detailed, daily, patient-specific adherence information. DATs provide opportunities for a more patient-centred care model and also help healthcare workers while treating tuberculosis (TB) patients when compared to traditional directly observed therapy. Hence, in this study explored the acceptance and barriers to the use of DATs for monitoring compliance with TB treatment and its possible solutions. Methods A community-based qualitative study was done in two PHCs in Puducherry, India among TB patients who completed treatment, healthcare providers such as tuberculosis health visitors, staff nurses, and respective medical officers. Thirty participants were interviewed using purposive sampling to explore TB treatment outcomes over two months (Oct-Nov 2023). In-depth interviews were conducted with the help of a separate interview guide consisting of broad, open-ended questions with two primary stimulus questions based on the acceptance and barriers for use of DATs for capturing adherence to TB treatment. The possible solutions for the barriers to the use of DATs were also explored by the healthcare providers. Manual content analysis was done for the qualitative data. Results Benefits of the use of DATs included saving time, identification of loss to follow up patients, information on NIKSHAY, and other direct benefit transfers. Barriers include financial constraints, level of education, family issues, and difficulty in the use of gadgets (tab). Some of the solutions to the barriers were cooperation from family members, distribution of mobile phones, appointment of ASHA workers, and linking of NIKSHAY IDs with Aadhaar card numbers to avoid duplication. Interpretation & Conclusions Identification of barriers and potential solutions in DATs can help in the successful monitoring and completion of tuberculosis treatment which are crucial towards achieving the tuberculosis elimination goal set by the Government of India as well as the SDG target for elimination by 2030.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.